124 related articles for article (PubMed ID: 17303233)
1. Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine.
Frankel PS; Hoonakker AJ; Danaceau JP; Hanson GR
Pharmacol Biochem Behav; 2007 Mar; 86(3):511-5. PubMed ID: 17303233
[TBL] [Abstract][Full Text] [Related]
2. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.
Hall DA; Stanis JJ; Marquez Avila H; Gulley JM
Psychopharmacology (Berl); 2008 Jan; 195(4):469-78. PubMed ID: 17874316
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
4. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
5. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats.
Gentry WB; Laurenzana EM; Williams DK; West JR; Berg RJ; Terlea T; Owens SM
Int Immunopharmacol; 2006 Jun; 6(6):968-77. PubMed ID: 16644483
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
Rivière GJ; Byrnes KA; Gentry WB; Owens SM
J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
[TBL] [Abstract][Full Text] [Related]
8. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
9. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
[TBL] [Abstract][Full Text] [Related]
10. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction.
Shoblock JR; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Nov; 170(2):150-6. PubMed ID: 12774190
[TBL] [Abstract][Full Text] [Related]
11. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
[TBL] [Abstract][Full Text] [Related]
12. Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection.
McCoy MT; Jayanthi S; Wulu JA; Beauvais G; Ladenheim B; Martin TA; Krasnova IN; Hodges AB; Cadet JL
Psychopharmacology (Berl); 2011 May; 215(2):353-65. PubMed ID: 21229349
[TBL] [Abstract][Full Text] [Related]
13. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine-induced locomotor changes are dependent on age, dose and genotype.
Good RL; Radcliffe RA
Pharmacol Biochem Behav; 2011 Mar; 98(1):101-11. PubMed ID: 21163294
[TBL] [Abstract][Full Text] [Related]
15. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex.
Stephans SE; Yamamoto BY
Brain Res; 1995 Nov; 700(1-2):99-106. PubMed ID: 8624733
[TBL] [Abstract][Full Text] [Related]
16. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
Hall DA; Powers JP; Gulley JM
Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain.
Wang JQ; McGinty JF
J Pharmacol Exp Ther; 1995 May; 273(2):909-17. PubMed ID: 7752096
[TBL] [Abstract][Full Text] [Related]
18. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
Bayat AH; Haghparast A
Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
[TBL] [Abstract][Full Text] [Related]
19. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
Segal DS; Kuczenski R
Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
[TBL] [Abstract][Full Text] [Related]
20. Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.
Hambuchen MD; Rüedi-Bettschen D; Gunnell MG; Hendrickson H; Owens SM
Hum Vaccin Immunother; 2016 Sep; 12(9):2240-8. PubMed ID: 27163775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
